Pioneering study reveals 7 out of 10 heart attack patients have diabetes

A two year study, the first of its kind in the Middle East, conducted by the Jordanian Cardiologists Association and funded by Hikma Pharmaceuticals revealed that approximately 70 % of heart attack patients are diabetic.

Press Release Product 8 March 2010

Cardiovascular disease (CVD) is the most common cause of death worldwide and in the Middle East including Jordan. Diabetes mellitus (DM) is a major risk factor for CVD and its incidence is rising in the Middle East. Compared with the general population, diabetics face a two- to fourfold increased risk of CVD. In this context, 5 Jordanian studies and registries involving heart attack patients revealed that the overall prevalence of diabetes in Jordan was 48%, similar to the results of a study done in the Arab Gulf countries (45%).

Compared with non-diabetics, diabetics tend to have more severe outcomes and potentially higher death rates when they suffer a heart attack.


Among heart attack patients enrolled in the study, it was found that 45% were known to be diabetics, 11% have new-onset DM, 13% have latent diabetes, and only 31% were nondiabetics. This indicates that about 7 of every ten 10 heart attack patients have some form of diabetes, an alarmingly high rate.

In summary, diabetes afflicts 7 of every 10 patients admitted with heart attacks. Diabetics also tend to suffer more complications.

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.